The FDA is still on track to meet its user fee targets despite a higher-than-normal vacancy rate among scientific reviewers.

Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...

George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and ...

An estimated 53 drugs would not enter the market in the next 30 years if the NIH is hit with a permanent 10% budget cut and the FDA experiences a nine-month drug review delay due to staffing cuts, the ...

St. Paul Public Library says the Rondo location is closing early on Saturdays and staying closed on Sundays due to limited ...

The Trump administration has touted AI as a way to cut government staffing, but the FDA's new AI tool has been citing ...

Last Monday, the U.S. Department of Health and Human Services (HHS) finalized 10,000 layoffs across federal health agencies, including the National Institutes of Health (NIH), U.S. Food and Drug ...

Tidmarsh, who has founded and served as CEO of several biotech companies, will lead a crucial FDA division that reviews the ...

"What's so beautiful about not helping people?" asked one participant in the Veteran's Alcoholic Rehabilitation Program. "Why ...

The Trump administration's proposed cuts at the NIH and FDA could lower the number of new drugs that come to market in the next three decades, according to a CBO analysis. Under hypothetical scenarios ...

For the past month, the Rondo Community Library on Dale Street has shut its doors at 2 p.m. on Saturdays and stayed closed ...

The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...